FI970426A - Menetelmä mikrobinvastaisten kinolonyylilaktaamien valmistamiseksi ja uusia välituotteita - Google Patents
Menetelmä mikrobinvastaisten kinolonyylilaktaamien valmistamiseksi ja uusia välituotteita Download PDFInfo
- Publication number
- FI970426A FI970426A FI970426A FI970426A FI970426A FI 970426 A FI970426 A FI 970426A FI 970426 A FI970426 A FI 970426A FI 970426 A FI970426 A FI 970426A FI 970426 A FI970426 A FI 970426A
- Authority
- FI
- Finland
- Prior art keywords
- lactams
- preparation
- novel intermediates
- antimicrobial quinolone
- quinolone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/02—Preparation
- C07D463/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28477194A | 1994-08-02 | 1994-08-02 | |
PCT/US1995/009649 WO1996004286A1 (en) | 1994-08-02 | 1995-08-01 | Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970426A0 FI970426A0 (fi) | 1997-01-31 |
FI970426A true FI970426A (fi) | 1997-03-25 |
Family
ID=23091468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970426A FI970426A (fi) | 1994-08-02 | 1997-01-31 | Menetelmä mikrobinvastaisten kinolonyylilaktaamien valmistamiseksi ja uusia välituotteita |
Country Status (13)
Country | Link |
---|---|
US (1) | US5801242A (es) |
EP (1) | EP0775145A1 (es) |
JP (1) | JPH10503521A (es) |
KR (1) | KR100239200B1 (es) |
CN (1) | CN1159809A (es) |
AU (1) | AU3154095A (es) |
BR (1) | BR9508513A (es) |
CA (1) | CA2196539C (es) |
FI (1) | FI970426A (es) |
MX (1) | MX9700872A (es) |
NO (1) | NO970428L (es) |
NZ (1) | NZ290722A (es) |
WO (1) | WO1996004286A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020443A (en) * | 1996-02-08 | 2000-02-01 | Advanced Polymer Technologies, Inc. | Polymerization of low grade DCPD monomers using an olefin metathesis catalyst |
EP1280808A1 (en) * | 2000-05-02 | 2003-02-05 | NewBiotics, Inc. | Improved beta-lactam antibiotics |
DE60112325T2 (de) * | 2000-12-14 | 2006-05-24 | The Procter & Gamble Company, Cincinnati | Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen |
US6803469B2 (en) | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE279886C (es) * | ||||
US4383946A (en) * | 1980-03-27 | 1983-05-17 | Merck & Co., Inc. | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals |
NL8005041A (nl) * | 1980-09-05 | 1982-04-01 | Gist Brocades Nv | Werkwijze voor de bereiding van thioethers, alsmede gesilyleerde thiolen voor toepassing bij deze werkwijze. |
US4546176A (en) * | 1982-12-14 | 1985-10-08 | Eisai Co., Ltd. | 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same |
EP0181521A1 (en) * | 1984-10-19 | 1986-05-21 | Otsuka Pharmaceutical Co., Ltd. | Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds |
US4755513A (en) * | 1985-01-30 | 1988-07-05 | Otsuka Pharmaceutical Company, Limited | Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds |
DE3509769A1 (de) * | 1985-03-19 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von carbapenemzwischenprodukten |
US4684648A (en) * | 1985-05-10 | 1987-08-04 | Otsuka Pharmaceutical Company Limited | Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof |
DE3542644A1 (de) * | 1985-12-03 | 1987-06-04 | Hoechst Ag | Verfahren zur herstellung von cefodizim |
JPS62215591A (ja) * | 1986-03-14 | 1987-09-22 | Dainippon Pharmaceut Co Ltd | ピリドベンズオキサジン誘導体の製造法およびその中間体 |
EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
CS273349B2 (en) * | 1988-03-31 | 1991-03-12 | Hoffmann La Roche | Method of cephalosporin's new derivatives production |
US5328908A (en) * | 1988-10-24 | 1994-07-12 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolone thioureas |
US5273973A (en) * | 1988-10-24 | 1993-12-28 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl esters |
EP0366193A3 (en) * | 1988-10-24 | 1992-01-08 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial quinolonyl lactams |
SG67307A1 (en) * | 1988-10-24 | 1999-09-21 | Procter & Gamble Pharma | Novel antimicrobial quinolonyl lactam esters |
ZA912279B (en) * | 1990-04-09 | 1992-02-26 | Hoffmann La Roche | Carbapenem compounds |
KR920004385A (ko) * | 1990-08-09 | 1992-03-27 | 와꾸나가 기스께 | 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제 |
IT1248011B (it) * | 1991-06-07 | 1995-01-05 | Mediolanum Farmaceutici Spa | Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato. |
EP0606336B1 (en) * | 1991-10-01 | 1997-03-19 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Process for making antimicrobial quinolonyl lactams |
EG20543A (en) * | 1992-10-30 | 1999-07-31 | Procter & Gamble | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones |
-
1995
- 1995-08-01 WO PCT/US1995/009649 patent/WO1996004286A1/en not_active Application Discontinuation
- 1995-08-01 NZ NZ290722A patent/NZ290722A/xx unknown
- 1995-08-01 MX MX9700872A patent/MX9700872A/es unknown
- 1995-08-01 CN CN95195416A patent/CN1159809A/zh active Pending
- 1995-08-01 CA CA002196539A patent/CA2196539C/en not_active Expired - Fee Related
- 1995-08-01 JP JP8506674A patent/JPH10503521A/ja active Pending
- 1995-08-01 KR KR1019970700704A patent/KR100239200B1/ko not_active IP Right Cessation
- 1995-08-01 AU AU31540/95A patent/AU3154095A/en not_active Abandoned
- 1995-08-01 EP EP95927542A patent/EP0775145A1/en not_active Withdrawn
- 1995-08-01 BR BR9508513A patent/BR9508513A/pt not_active Application Discontinuation
-
1997
- 1997-01-31 FI FI970426A patent/FI970426A/fi unknown
- 1997-01-31 NO NO970428A patent/NO970428L/no not_active Application Discontinuation
- 1997-11-12 US US08/968,987 patent/US5801242A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO970428L (no) | 1997-04-02 |
KR100239200B1 (ko) | 2000-03-02 |
CN1159809A (zh) | 1997-09-17 |
US5801242A (en) | 1998-09-01 |
EP0775145A1 (en) | 1997-05-28 |
FI970426A0 (fi) | 1997-01-31 |
MX9700872A (es) | 1997-05-31 |
WO1996004286A1 (en) | 1996-02-15 |
CA2196539A1 (en) | 1996-02-15 |
NO970428D0 (no) | 1997-01-31 |
CA2196539C (en) | 2001-05-15 |
BR9508513A (pt) | 1998-06-02 |
NZ290722A (en) | 1999-03-29 |
AU3154095A (en) | 1996-03-04 |
JPH10503521A (ja) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI953883A0 (fi) | Menetelmä maitohapon erottamiseksi ja puhdistamiseksi | |
FI951439A (fi) | Mikro-organismit tryptofaanin tuottamista varten ja näiden valmistusmenetelmät | |
FI20090217A (fi) | Menetelmä elintarvikekoostumuksen valmistamiseksi | |
FI943249A (fi) | Menetelmä vastaanottimen ohjaamiseksi ja vastaanotin | |
NO993644D0 (no) | Fremgangsmåte for fremstilling av semisyntetiske statiner via nye mellomprodukter | |
FI960278A (fi) | Anataasititaanidioksidin valmistusmenetelmä | |
FI940874A (fi) | Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi | |
FI990171A0 (fi) | Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi | |
FI952585A (fi) | Menetelmä bentsopyraaniyhdisteiden valmistamiseksi | |
FI942907A (fi) | Menetelmä lipaasin valmistamiseksi | |
FI971138A0 (fi) | Keraamisia eristeitä ja menetelmiä niiden muodostamiseksi | |
FI93119B (fi) | Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä | |
FI970426A (fi) | Menetelmä mikrobinvastaisten kinolonyylilaktaamien valmistamiseksi ja uusia välituotteita | |
FI932863A (fi) | Foerfarande foer framstaellning av nya tienotiazinderivat och deras anvaendning | |
FI956058A (fi) | Menetelmä glutaaridialdehydin valmistamiseksi | |
FI953361A0 (fi) | Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi | |
FI972464A0 (fi) | Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
FI971378A0 (fi) | Menetelmiä ja välituotteita 3-aminobentso(b)-atsepinonien valmistusta varten | |
FI102841B1 (fi) | Menetelmä mannitolin valmistamiseksi | |
FI901550A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten di-imidatsopyrimidiini- ja imidatsopyratsolopyrimidiinijohdannaisten valmistamiseksi | |
DE59510416D1 (de) | Verfahren zur Herstellung von Chlormethylpyridin Derivaten und Acylaminomethylpyridine als Zwischenprodukte | |
FI971964A0 (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi | |
FI951441A (fi) | Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi | |
DE69510390D1 (de) | Verfahren zur Herstellung von Allylchinon-Derivaten und Zwischenprodukte |